Acute coronary syndromes (ACS) is an umbrella term used to describe a series of signs and symptoms indicative of myocardial ischemia, comprising unstable angina, non-ST segment elevation myocardial infarction, and ST segment elevation myocardial infarction.
Managing Acute Coronary Syndromes in Clinical Practice is an essential resource for the clinician in the management of ACS. In addition to providing a comprehensive overview of the epidemiology and clinical presentation of ACS, it also guides the reader through risk assessment, risk stratification, diagnosis, and treatment of ACS. The book concludes with a discussion on emerging technologies in the treatment of ACS. The handbook format and ample use of illustrations make this pocketbook an excellent resource for General Practitioners, Emergency Medicine Physicians, Nurses, Nurse Practitioners, Pharmacists, Physician Trainees, Medical Students, Nursing Students, and Paramedics who wish to keep up-to-date with recent advances in the understanding and treatment of ACS.
Written for: General and family practice physicians, internists, cardiologists, emergency medicine physicians, physicians in training, medical students, nurse practitioners, nurse clinicians, and pharmacists
Table of contents
1 Preface.- 2 Epidemiology – US, European, and global perspectives; unstable angina, NSTEMI, STEMI.- 3 Diagnosis – symptoms, biomarkers, ECG.- 4 Risk stratification – TIMI risk score, GRACE risk score, CRUSADE/PURSUIT risk score.- 5 Medical therapy – antithrombotics, statins, etc.- 6 Percutaneous therapy – culprit vessel versus mulitvessel; BMS vs DES.- 7 Surgical therapy.- 8 Prognosis. - 9 Controversies – optimal antithrombotic strategy, fibrinolysis versus primary PCI for STEMI, preferred mode of revascularization (bare metal stents versus drug eluting stents versus CABG). - 10 Future approaches – CT angio and other evolving imaging modalities, biomarkers, proteomics, genomics, angiogenesis, myogenesis. Appendix A – Practice Guidelines – ACC/AHA and ESC.- Appendix B – Synopsis of Key Trials